top of page
CHS Conference Logo.png

PRESENTATIONS

Paul Cooper, MD

Acute Migraine Treatment
Upon completion of this activity, learners will be able to:

  • Recommend an acute treatment for your patient’s migraine headaches

  • Alter that treatment based on the patient’s response

  • Use guidelines to inform your choice for acute migraine treatments

Suzanne Christie, MD, Ioana Medrea, MD

Migraine Prevention – The Guidelines and Beyond

Upon completion of this activity, learners will be able to:

  • Review migraine prevention strategies, first line and beyond

  • Go over special situations for migraine prevention such as treatment refractory patients, pregnancy, lactation

  • Review of pertinent literature since literature search

​Marissa Lagman, MD

Headaches That Won’t Go Away

Upon completion of this activity, learners will be able to:

  • Develop an approach to evaluation and diagnosis of chronic daily headache (CDH) in children & adolescents

  • Review the differential diagnosis for CDH in the young

  • Discuss the updates in diagnosis and management of new daily persistent headache (NDPH)

Tommy Chan, MD

When the Pressure Drops and the Vessels Narrow: A Complex Case of Headache Overlap

Elizabeth Leroux, MD

A Case of Chronic Migraine

Upon completion of this activity, learners will be able to:

  • Detail the management of chronic migraine over time and the relevance of combination therapy

  • Emphasize the importance of a headache diary

  • Underline the relevance of life events and comorbidities on the clinical management of chronic migraine

Claire Sandoe, MD, Ioana Medrea, MD

Cluster + Case

Upon completion of this activity, learners will be able to:

  • Describe the epidemiology, diagnostic criteria, and workup of cluster headache

  • Understand evidence-based management of cluster headache over the life cycle

  • Identify considerations when treating cluster headache in special cases e.g. pregnancy and chronic cluster

Farnaz Amoozegar, MD, Will Kingston, MD

Medication Overuse Headache

Upon completion of this activity, learners will be able to:

  • Define Medication Overuse Headache (MOH)

  • Describe the pathophysiology of MOH

  • Become familiar with an approach to management

  • Discuss the various treatment options for MOH

Alex Melinyshyn, MD, Danny Monsour, MD, Gary Shapero, MD, Leslie Witton, MD

Transition of Care Clinical Guidance

After attending this presentation, participants will be better able to:

  • Identify practical, evidence-informed strategies primary care providers can implement as stopgap measures to manage headache patients while awaiting specialist consultation

  • Demonstrate how to effectively use the CHS-developed referral feedback tool to support continuity of care and empower primary care providers with tailored, actionable treatment recommendations

  • Describe key considerations and best practices for transitioning headache patients from specialist care back to primary care, with a focus on ensuring continuity of prescriptions and monitoring of new therapies such as CGRP pathway-targeting medications

  • Enhance communication and collaboration between primary care and specialist providers to reduce care gaps, optimize patient outcomes, and streamline shared management of complex headache disorders

Tesha Monteith, MD

Raising the Standards of Migraine Care for All

Upon completion of this activity, learners will be able to:

  • Recognize disparities, the impact of social determinants of health, and barriers in migraine care

  • Apply IHS recommendations for essential and optimal care

  • Evaluate interventions that improve access and equity

  • Advocate for raising the global standard of migraine care

David Dodick, MD

Prodrome & Cognition

​Robert Maunder, MD, Orit Zamir, MD

Migraine and ACEs

Upon completion of this activity, learners will be able to:

  • Consider the prevalence and impact of trauma and childhood adversity and on migraine

  • Explain the relationship between stress and migraine

James Im, MD

Migraine and Sleep

Upon completion of this activity, learners will be able to:

  • Describe a broad overview of basic sleep physiology

  • Be able to obtain a sleep history and describe methods to measure and assess sleep

  • Be able to diagnose and describe treatment of insomnia in the context of migraine

  • Be able to describe treatment effects of migraine medications on sleep

  • Discuss sleep apnea headache, pathophysiology and treatment

  • Discuss new discoveries and implications of CGRP and PACAP involving sleep 

Claire Sandoe, MD, Tesha Monteith, MD

Headache and Hormones

Upon completion of this activity, learners will be able to:

  • Describe the impact of hormones on headache over a woman’s lifetime

  • Understand the approach to treatment of migraine in pregnancy and lactation

  • Identify considerations around migraine with aura and hormone treatment

**Not covered today: Gender-affirming hormone therapy (GAHT)

Darren Tse, MD

Vestibular Migraine: Dizziness Hiding in Plain Sight

Upon completion of this activity, learners will be able to:

  • Describe the current diagnostic criteria for vestibular migraine

  • Identify critical aspect of clinical history and examination in patients with vestibular migraine

  • Differentiate between vestibular migraine and other causes of episodic vestibular syndrome

​Alex Melinyshyn, MD

Treatment of Headache in the Older Patient

By the end of this session, attendees will be better equipped to:

  • Recognize the epidemiology and clinical spectrum of primary and secondary headache disorders in older adults

  • Differentiate between typical migraine and new-onset headache in late life, emphasizing red flags and secondary causes

  • Identify common secondary headache etiologies in the late life e.g., temporal arteritis, intracranial mass, vascular disorders, medication overuse, sleep apnea)

  • Apply appropriate diagnostic strategies, including when to order neuroimaging, vascular imaging, or laboratory investigations

  • Evaluate safety and tolerability profiles of acute and preventive headache medications in older adults, including drug–drug interactions and polypharmacy concerns

bottom of page